Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 21, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 62
- −1 vs. Q1 2023
- Portfolio value
- $254.1M
- −$6.12M (−2.4%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 92,500 | $21.4M | 8.4% | −500−0.5% | Reduced | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 550,000 | $17.5M | 6.9% | +170,000+44.7% | Added | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 211,608 | $14.5M | 5.7% | +98,384+86.9% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 321,017 | $12.3M | 4.9% | −655,004−67.1% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,600,000 | $12.0M | 4.7% | +1,600,000 | New | History |
| MORFMorphic Holding, Inc. | COM | 201,887 | $11.6M | 4.6% | +66,024+48.6% | Added | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,050,118 | $11.5M | 4.5% | −33,000−3.0% | Reduced | History |
| BIIBBiogen Inc. | COM | 40,000 | $11.4M | 4.5% | +40,000 | New | History |
| KURAKura Oncology, Inc. | COM | 910,317 | $9.63M | 3.8% | +553,030+154.8% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 447,667 | $9.46M | 3.7% | −5,154−1.1% | Reduced | History |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $9.45M | 3.7% | – | – | – |
| ACLXArcellx, Inc. | COMMON STOCK | 226,275 | $7.15M | 2.8% | +23,441+11.6% | Added | History |
| PRTAProthena Corp Public Ltd Co | SHS | 100,000 | $6.83M | 2.7% | +100,000 | New | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 900,723 | $5.58M | 2.2% | +216,596+31.7% | Added | History |
| ATXSAstria Therapeutics, Inc. | COM | 650,875 | $5.42M | 2.1% | +121,506+23.0% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 57,760 | $5.16M | 2.0% | +17,760+44.4% | Added | History |
| IMVTImmunovant, Inc. | COM | 260,000 | $4.93M | 1.9% | +260,000 | New | History |
| VKTXViking Therapeutics, Inc. | COM | 300,000 | $4.86M | 1.9% | −322,249−51.8% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $4.29M | 1.7% | 00.0% | Unchanged | History |
| INZYInozyme Pharma, Inc. | COM | 751,796 | $4.19M | 1.6% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 125,148 | $4.08M | 1.6% | −96,315−43.5% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,589,017 | $3.78M | 1.5% | +1,589,017 | New | History |
| IMTXImmatics N.V. | SHS | 300,000 | $3.46M | 1.4% | +300,000 | New | History |
| Esperion Therapeutics Inc Ne29664WAB1 | NOTE 4.000%11/1 | – | $3.44M | 1.4% | – | – | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 130,000 | $3.41M | 1.3% | +130,000 | New | History |
| VTYXVentyx Biosciences, Inc. | COM | 100,696 | $3.30M | 1.3% | −159,312−61.3% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 29,105 | $2.97M | 1.2% | +29,105 | New | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 87,031 | $2.95M | 1.2% | +37,031+74.1% | Added | History |
| KYNBKyntra Bio, Inc. | COM | 983,300 | $2.65M | 1.0% | +983,300 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 60,376 | $2.32M | 0.9% | −29,624−32.9% | Reduced | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 240,244 | $2.24M | 0.9% | +142,023+144.6% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM | 4,900,000 | $2.21M | 0.9% | +4,900,000 | New | History |
| VINCVincerx Pharma, Inc. | COM NEW | 1,492,771 | $1.94M | 0.8% | 00.0% | Unchanged | History |
| LIANYLianBio | SPONSORED ADS | 800,676 | $1.83M | 0.7% | +150,676+23.2% | Added | History |
| CABACabaletta Bio, Inc. | COM | 125,000 | $1.61M | 0.6% | +125,000 | New | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 178,292 | $1.60M | 0.6% | −30,000−14.4% | Reduced | History |
| Intrexon Corp46122TAA0 | NOTE 3.500% 7/0 | – | $1.51M | 0.6% | – | – | – |
| ADCTADC Therapeutics SA | SHS | 600,000 | $1.29M | 0.5% | 00.0% | Unchanged | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 187,675 | $1.28M | 0.5% | +187,675 | New | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 150,000 | $1.26M | 0.5% | +150,000 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 118,891 | $1.22M | 0.5% | −129,000−52.0% | Reduced | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 100,000 | $1.19M | 0.5% | +100,000 | New | History |
| IFRXInflaRx N.V. | COM | 240,200 | $1.07M | 0.4% | +240,200 | New | History |
| MLYSMineralys Therapeutics, Inc. | COM | 62,500 | $1.07M | 0.4% | 00.0% | Unchanged | History |
| NRIXNurix Therapeutics, Inc. | COM | 100,000 | $999.0K | 0.4% | −50,000−33.3% | Reduced | History |
| BCABBioAtla, Inc. | COM | 325,000 | $975.0K | 0.4% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 10,000 | $911.0K | 0.4% | −25,000−71.4% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 12,500 | $898.3K | 0.4% | +12,500 | New | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 300,068 | $855.2K | 0.3% | +100,686+50.5% | Added | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 30,000 | $776.1K | 0.3% | −65,000−68.4% | Reduced | History |
| PBYIPuma Biotechnology, Inc. | COM | 202,349 | $714.3K | 0.3% | +25,000+14.1% | Added | History |
| PCVXVaxcyte, Inc. | COM | 13,923 | $695.3K | 0.3% | −48,300−77.6% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM | 476,948 | $653.4K | 0.3% | 00.0% | Unchanged | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $632.8K | 0.2% | 00.0% | Unchanged | – |
| TRMLTourmaline Bio, Inc. | COM | 200,000 | $608.0K | 0.2% | +200,000 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 35,133 | $604.3K | 0.2% | −284,867−89.0% | Reduced | History |
| VIRVir Biotechnology, Inc. | COM | 20,000 | $490.6K | 0.2% | +20,000 | New | History |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $450.0K | 0.2% | 00.0% | Unchanged | History |
| NLS Pharmaceutics LtdH57830103 | SHS | 400,000 | $440.0K | 0.2% | +55,911+16.2% | Added | – |
| CNTXContext Therapeutics Inc. | COM | 267,574 | $428.1K | 0.2% | +267,574 | New | History |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 37,000 | $77.3K | <0.1% | 00.0% | Unchanged | History |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $13.9K | <0.1% | 00.0% | Unchanged | – |
Options (6)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| MDGLMadrigal Pharmaceuticals, Inc. | COM | – | $12.3M |
| BBIOBridgeBio Pharma, Inc. | COM | $6.47M | – |
| VKTXViking Therapeutics, Inc. | COM | $5.67M | – |
| KYNBKyntra Bio, Inc. | COM | $2.65M | $918.0K |
| VRDNViridian Therapeutics, Inc. | COM | – | $3.10M |
| ARAVAravive, Inc. | COM | $1.09M | $42.3K |
Sold out since Q1 2023 (20)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 150,000 | $16.1M | 6.2% | History |
| MRKMerck & Co., Inc. | Stock | 120,000 | $12.8M | 4.9% | History |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $7.12M | 2.7% | – |
| Bellus Health Inc New07987C204 | COM NEW | 881,329 | $6.35M | 2.4% | – |
| SGENSeagen Inc. | COM | 20,000 | $4.05M | 1.6% | History |
| ARGXArgenx SE | SPONSORED ADR | 10,750 | $4.01M | 1.5% | History |
| ETNB89bio, Inc. | COM | 200,000 | $3.05M | 1.2% | History |
| LNTHLantheus Holdings, Inc. | Stock | 30,244 | $2.50M | 1.0% | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 25,000 | $2.43M | 0.9% | History |
| KRTXKaruna Therapeutics, Inc. | COM | 12,500 | $2.27M | 0.9% | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 20,000 | $2.18M | 0.8% | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 460,979 | $1.79M | 0.7% | History |
| COGTCogent Biosciences, Inc. | COM | 143,064 | $1.54M | 0.6% | History |
| NARIInari Medical, Inc. | Stock | 20,000 | $1.23M | 0.5% | History |
| PNTPOINT Biopharma Global Inc. | COM | 149,586 | $1.09M | 0.4% | History |
| FHTXFoghorn Therapeutics Inc. | COM | 136,771 | $848.0K | 0.3% | History |
| ROIVRoivant Sciences Ltd. | SHS | 100,000 | $738.0K | 0.3% | History |
| Pieris Pharmaceuticals Inc720795103 | COM | 306,950 | $299.6K | 0.1% | – |
| SCLXWScilex Holding Co | *W EXP 11/10/202 | 18,099 | $19.0K | <0.1% | History |
| SCLXScilex Holding Co | COM | 463 | $3.80K | <0.1% | History |